| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Title | DOI | category | Year | commentary | last author location | last author latitude | last author longitude | last author country | ||||||||||||||||
2 | Collagen VI-Related Dystrophies | https://www.ncbi.nlm.nih.gov/books/NBK1503/ | basic | ongoing | |||||||||||||||||||||
3 | Progressive proximal weakness with contractures and respiratory failure: an unusual presentation of Bethlem myopathy | 10.1136/pn-2026-005105 | clinical | 2026 | Colombo | 6.93 | 79.86 | Sri Lanka | |||||||||||||||||
4 | Neonatal Hypotonia with an Incomplete Genotype–Phenotype Correlation: A Diagnostic Challenge Suggestive of Ullrich Congenital Muscular Dystrophy | 10.4103/jpn.jpn_13_26 | clinical | 2026 | Lucknow | 26.85 | 80.95 | India | |||||||||||||||||
5 | Hair Follicle Microenvironment Changes in Collagen VI-Myopathy Patients with Alopecia | 10.3390/cells15151351 | clinical | 2026 | Bologna | 44.49 | 11.34 | Italy | |||||||||||||||||
6 | Expanding the phenotypic spectrum of COL6-related diseases: Motor neuropathy-like and neuromyopathy associated with COL6A3 c.7447A>G | 10.1177/22143602261453996 | clinical | 2026 | Paris | 48.85 | 2.35 | France | |||||||||||||||||
7 | Hypophosphatasia and collagen VI-related muscular dystrophy presenting with gait disturbance and recurrent fractures. | 10.1210/jcemcr/luag170 | clinical | 2026 | Suwon | 37.27 | 127.05 | South Korea | |||||||||||||||||
8 | Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies | 10.1038/s44319-026-00834-0 | basic | 2026 | Paris | 48.85 | 2.35 | France | |||||||||||||||||
9 | Ageing impacts extracellular matrix turnover and remodelling in the kidney | 10.1016/j.mbplus.2026.100197 | basic | 2026 | contains half-life of COL6 in the mouse kidney | South Korea | |||||||||||||||||||
10 | AXOLOTL: an accurate method for detecting aberrant gene expression in rare diseases using coexpression constraints | 10.1101/2024.01.07.574502 | basic | 2026 | also includes COL6 patients; preprint | Beijing | 39.9 | 116.4 | China | ||||||||||||||||
11 | Collagen VI–Related Myopathies: An Educational Overview of Molecular Pathogenesis, Variability of Clinical Presentations Spectrum, Diagnostic Approaches and Management Strategies | 10.38124/ijisrt/26apr353 | review | 2026 | Stockton | 1.19 | 54.34 | UK | |||||||||||||||||
12 | A zebrafish model of Bethlem myopathy reveals CaV1.1 as the missing link between collagen type VI deficiency and muscle dysfunction. | 10.1101/2025.06.02.657388 | basic | 2026 | preprint | Lyon | 45.76 | 4.83 | France | ||||||||||||||||
13 | Autosomal recessive Bethlem myopathy: a 30-year journey | 10.1007/s00415-025-13214-w | clinical | 2025 | Milan | 45.46 | 9.18 | Italy | |||||||||||||||||
14 | Antxr2-mediated fine-tuning of Collagen VI ensures skeletal muscle function | 10.1101/2025.09.11.675515 | basic | 2025 | preprint | Padova | 45.4 | 11.88 | Italy | ||||||||||||||||
15 | Psychological aspects in neuromuscular patients: case series | 10.36185/2532-1900-1168 | clinical | 2025 | including one BM case | Naples | 40.85 | 14.27 | Italy | ||||||||||||||||
16 | Landscape Analysis of COL6A1, COL6A2, and COL6A3 Pathogenic Variants in a Large Italian Cohort Presenting with Collagen VI-Related Myopathies: A Nationwide Report | 10.3390/biom15101426 | clinical | 2025 | Ferrara | 44.83 | 11.62 | Italy | |||||||||||||||||
17 | The Absence of Collagen VI Reduces Systolic Function but Paradoxically Increases Ca2+ Release in the Rat Heart | 10.1111/apha.70144 | basic | 2025 | Auckland | -36.85 | 174.76 | New Zealand | |||||||||||||||||
18 | Tendon Dysfunction in Collagen VI-Related Myopathies: Novel Mechanistic Insights with Therapeutic Potential | 10.3390/ijms262412014 | basic | 2025 | Bologna | 44.49 | 11.34 | Italy | |||||||||||||||||
19 | Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy | 10.7759/cureus.97510 | clinical | 2025 | Najran | 17.56 | 44.23 | Saudi Arabia | |||||||||||||||||
20 | Generation and Characterization of Col6a1 knock-in mice: A Promising Pre-Clinical Model for Collagen VI-Related Dystrophies | 10.1101/2025.03.11.642560 | basic | 2025 | preprint | Barcelona | 41.39 | 2.17 | Spain | ||||||||||||||||
21 | Clinical and Genetic Landscape of Children With Congenital Muscular Dystrophies From North India | 10.1177/08830738251374530 | clinical | 2025 | Chandigarh | 30.73 | 76.78 | India | |||||||||||||||||
22 | Defective collagen VI-NG2 axis impairs pericyte balance between proliferation and quiescence in COLVI-related myopathies | 10.1016/j.bbadis.2025.168012 | basic | 2025 | Bologna | 44.49 | 11.35 | Italy | |||||||||||||||||
23 | The absence of collagen VI reduces systolic function but paradoxically increases Ca2+ release in the rat heart | 10.1101/2025.03.21.644665 | basic | 2025 | preprint | Auckland | -36.50 | 174.45 | New Zealand | ||||||||||||||||
24 | Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations | 10.1038/s41467-025-62923-3 | basic | 2025 | Manchester | 53.29 | 2.14 | UK | |||||||||||||||||
25 | Novel variant of COL12A1 gene causing neonatal hypotonia and respiratory failure | 10.1007/s10072-025-08028-7 | clinical | 2025 | Hefei | 31.82 | 117.23 | China | |||||||||||||||||
26 | A Challenge in Perioperative Anesthetic Management: A Case Report of an Infant With Concurrent Ullrich Congenital Muscular Dystrophy and Pierre Robin Sequence | 10.7759/cureus.82170 | clinical | 2025 | Detroit | 42.33 | -83.05 | USA | |||||||||||||||||
27 | Myopathies: Radiologist’s Essential Tips for Clinical, Pathologic, and Imaging Findings | 10.1148/rg.240190 | clinical | 2025 | includes Bethlem | Nara | 34.69 | 135.80 | Japan | ||||||||||||||||
28 | Multimodal Evaluation of Bethlem Myopathy with the c.788G > A Variant in the COL6A1 Gene: a case report with genetic, ultrasonographic, and structural-functional discordance correlations | 10.36185/2532-1900-1028 | clinical | 2025 | Bogota | 4.42 | -74.4 | Colombia | |||||||||||||||||
29 | The artificial intelligence challenge in rare disease diagnosis: A case study on collagen VI muscular dystrophy | 10.1016/j.compbiomed.2025.110610 | basic | 2025 | Barcelona | 41.23 | 2.11 | Spain | |||||||||||||||||
30 | Myopathic Ehlers-Danlos Syndrome (mEDS) Related to COL12A1: Two Novel Families and Literature Review | 10.3390/ijms26115387 | clinical | 2025 | |||||||||||||||||||||
31 | Substitutions of nucleotides at the 3' ends of COL6A1/2/3 exons induce exon skipping associated with collagen VI-related muscular dystrophies and therapeutic strategies | 10.1016/j.gim.2025.101431 | therapy | 2025 | Tokyo | Japan | |||||||||||||||||||
32 | Inter- and intra-familial phenotypic variability of autosomal dominant collagen VI related disorder | 10.1007/s10072-025-08124-8. | clinical | 2025 | Shanghai | 31.22 | 121.47 | China | |||||||||||||||||
33 | Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T | 10.1093/brain/awaf116 | basic | 2025 | Bethesda | 38.9 | -77 | USA | |||||||||||||||||
34 | Generation of an iPSC line (with isogenic control) from the PBMCs of a COL6A1 (c.1056 + 2T > A) Bethlem myopathy patient | 10.1016/j.scr.2025.103673 | basic | 2025 | Melbourne | -37.48 | 144.57 | Australia | |||||||||||||||||
35 | Whole exome sequencing in 33 patients revealed 4 novel variants in 11 limbs-girdle muscular dystrophy families | 10.1016/j.genrep.2025.102218 | basic | 2025 | has also a few patients with COL6A1 | Mardan | 34.206 | 72.0298 | Pakistan | ||||||||||||||||
36 | Nanomechanics of cell-derived matrices as a functional read-out in Collagen VI-related Congenital Muscular Dystrophies | 10.1101/2024.09.13.612824 | basic | 2025 | preprint | Barcelona | 41.23 | 2.11 | Spain | ||||||||||||||||
37 | Clinical characterization of Collagen XII-related disease caused by biallelic COL12A1 variants | 10.1002/acn3.52225 | basic | 2025 | COLXII | ||||||||||||||||||||
38 | Generation of a human induced pluripotent stem cell line (CRICKi021-A) from a patient with Ullrich congenital muscular dystrophy carrying a pathogenic mutation in the COL6A1 gene | 10.1016/j.scr.2024.103648 | basic | 2025 | stem cell line on the mutation COL6A1 c.930 + 189C > T in intron 11 | London | 51.5 | -0.11 | UK | ||||||||||||||||
39 | Collablots: Quantification of collagen VI levels and its structural disorganisation in cell cultures from patients with collagen VI-related dystrophies | 10.1111/nan.70020 | basic | 2025 | Barakaldo | 43.17 | -2.59 | Spain | |||||||||||||||||
40 | Novel variant of COL12A1 gene causing neonatal hypotonia and respiratory failure | 10.1007/s10072-025-08028-7 | clinical | 2025 | COL12 | ||||||||||||||||||||
41 | Collagen type VI regulates TGFβ bioavailability in skeletal muscle in mice | 10.1172/JCI173354 | basic | 2025 | Bethesda | 38.9 | -77 | USA | |||||||||||||||||
42 | Development, validation, and preliminary phenotypic characterization of a Col6a3 knockout mouse model targeting exon 3 | 10.1002/ame2.70063 | basic | 2025 | Quebec | 46.81 | -72.21 | Canada | |||||||||||||||||
43 | Splicing Switching of Alternative Last Exons Due to a Deletion Including Canonical Polyadenylation Site in COL6A2 Gene Causes Recessive UCMD | 10.1212/nxg.0000000000200137 | clinical | 2024 | Cairo | 30.04 | 31.24 | Egypt | |||||||||||||||||
44 | In a cohort of 961 clinically suspected Duchenne muscular dystrophy patients, 105 were diagnosed to have other muscular dystrophies (OMDs), with LGMD2E (variant SGCB c.544A>C) being the most common | 10.1002/mgg3.2123 | clinical | 2024 | Coimbatore | 11.02 | 76.96 | India | |||||||||||||||||
45 | Severe progressive respiratory involvement requiring ventilator support in autosomal recessive Bethlem myopathy. A case report | 10.36185/2532-1900-654 | clinical | 2024 | Naples | 40.8 | 14.3 | Italy | |||||||||||||||||
46 | Type VI Collagen Deficiency Causes Enhanced Periodontal Tissue Destruction | 10.1177/00220345241256306 | basic | 2024 | Bethesda | 38.9 | -77 | USA | |||||||||||||||||
47 | Mutations in COL6A Gene Family Responsible for Muscular Dystrophies in Three Unrelated Families | 10.61186/ibj.4018 | basic | 2024 | About three families with six patients in Iran | Tehran | 35.42 | 51.24 | Iran | ||||||||||||||||
48 | First year results and insights from the Mexican Rare Disease Patient Registry | 10.1016/j.rare.2024.100046 | basic | 2024 | 3 COL6 patients reported in Mexico | Santiago de Querétaro | 20.5 | -99.51 | Mexico | ||||||||||||||||
49 | Collagen VI: Role in synaptic transmission and seizure-related excitability | 10.1016/j.expneurol.2024.114911 | basic | 2024 | Lund | 55.42 | 13.11 | Sweden | |||||||||||||||||
50 | Characterization of Proteome Changes in Aged and Collagen VI-Deficient Human Pericyte Cultures | 10.3390/ijms25137118 | basic | 2024 | Milano | 45.46 | 9.18 | Italy | |||||||||||||||||
51 | Identification of key genes affecting ventilator-induced diaphragmatic dysfunction in diabetic mice | 10.3389/fgene.2024.1387688 | basic | 2024 | Wuhan | 30.35 | 114.18 | China | |||||||||||||||||
52 | COL12A1 Gene Variant and a Review of the Literature: A Case Report of Ullrich Congenital Muscular Dystrophy. | 10.1159/000536344 | basic | 2024 | case report | ||||||||||||||||||||
53 | A humanized knock-in Col6a1 mouse recapitulates a deep-intronic splice-activating variant | 10.1101/2024.03.21.581572 | basic | 2024 | preprint | Bethesda | 38.9 | -77 | USA | ||||||||||||||||
54 | The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy | 10.1101/2024.03.29.24304673 | basic | 2024 | preprint | Bethesda | 38.9 | -77 | USA | ||||||||||||||||
55 | Splicing Switching of Alternative Last Exons Due to a Deletion Including Canonical Polyadenylation Site in COL6A2 Gene Causes Recessive UCMD | 10.1212/NXG.0000000000200137 | basic | 2024 | new mutation | Kyoto | 35.1 | 135.46 | Japan | ||||||||||||||||
56 | Collagen VI Deficiency Impairs Tendon Fibroblasts Mechanoresponse in Ullrich Congenital Muscular Dystrophy | 10.3390/cells13050378 | basic | 2024 | Padova | 45.4 | 11.8 | Italy | |||||||||||||||||
57 | Native collagen VI delays muscle stem cell early differentiation | 10.1242/jcs.261419 | basic | 2024 | Bologna | 45.49 | 11.32 | Italy | |||||||||||||||||
58 | The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction | 10.3389/fmolb.2024.1376091 | basic | 2024 | Bryan | 30.4 | -96.22 | USA | |||||||||||||||||
59 | Chapter 6 - Type VI collagen | 10.1016/B978-0-443-15617-5.00004-4 | basic | 2024 | book chapter from Biochemistry of Collagens, Laminins and Elastin | Herlev | 55.72 | 12.43 | Denmark | ||||||||||||||||
60 | Segregation of the COL6A2 Variant (c.1817-3C>G) in a Consanguineous Saudi Family with Bethlem Myopathy | 10.3390/genes15111405 | clinical | 2024 | case report | Buraidah | 26.2 | 43.97 | Saudi Arabia | ||||||||||||||||
61 | A Novel Splice Site Variant in COL6A1 Causes Ullrich Congenital Muscular Dystrophy in a Consanguineous Malian Family | 10.1002/mgg3.70032 | clinical | 2024 | case report | Bamako | 12.39 | 8 | Mali | ||||||||||||||||
62 | Clinical, Pathologic, and Genetic Spectrum of Collagen VI–Related Disorder in China—A Retrospective Observational Multicenter Study | 10.1155/2024/3503253 | clinical | 2024 | Shanghai | 31.22 | 121.47 | China | |||||||||||||||||
63 | Clinical and Molecular Profiles of a Cohort of Egyptian Patients with Collagen VI-Related Dystrophy | 10.1007/s12031-024-02266-8 | clinical | 2024 | Cairo | 30 | 31.23 | Egypt | |||||||||||||||||
64 | Bethlem myopathy: A novel homozygous variant of c.385C>T (p.Arg129Cys) in the COL6A2 gene | 10.1002/ccr3.9306 | clinical | 2024 | Tehran | ||||||||||||||||||||
65 | Phenotype-genotype spectrum of a cohort of congenital muscular dystrophies: a single-centre experience from India | 10.1007/s10048-024-00776-6 | clinical | 2024 | Bengaluru | ||||||||||||||||||||
66 | Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma | 10.1111/cns.14802 | clinical | 2024 | Beijing | ||||||||||||||||||||
67 | Identification of novel variations in three cases with rare inherited neuromuscular disorder | 10.3892/etm.2024.12558 | clinical | 2024 | case report, new mutation | Shijiazhuang | |||||||||||||||||||
68 | A Mild But Typical Presentation of Bethlem Myopathy With a Novel In-Frame Deletion in COL6A1 - Almost Overlooked | 10.1212/WNL.0000000000209476 | clinical | 2024 | case report, new mutation | Berlin | |||||||||||||||||||
69 | Anaesthesia management of a patient with Bethlem Myopathy for elective tonsillectomy: a case report | 10.1186/s12871-024-02539-0 | clinical | 2024 | Drogheda | ||||||||||||||||||||
70 | Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts | 10.3390/biom14111412 | therapy | 2024 | Modena | ||||||||||||||||||||
71 | Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention | 10.3390/biom14111376 | therapy | 2024 | Stockholm | ||||||||||||||||||||
72 | Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice | 10.1186/s13287-024-03951-6 | therapy | 2024 | Kyoto | ||||||||||||||||||||
73 | Allele-specific CRISPR/Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy | 10.1101/2024.03.22.586265. | therapy | 2024 | Bethesda | ||||||||||||||||||||
74 | Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1−/− mouse model of collagen VI‐related myopathies | 10.1002/ctm2.1688 | therapy | 2024 | Padova | ||||||||||||||||||||
75 | Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing | 10.1016/j.omtn.2024.102237 | therapy | 2024 | London | ||||||||||||||||||||
76 | Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy | 10.1212/NXG.0000000000200148 | therapy | 2024 | Bethesda | ||||||||||||||||||||
77 | Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy | 10.1016/j.omtn.2024.102178 | therapy | 2024 | Bethesda | ||||||||||||||||||||
78 | Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice | 10.1126/scitranslmed.abn8529 | therapy | 2024 | Sherbrooke | ||||||||||||||||||||
79 | Exome sequencing identifies genes associated with sleep-related traits (COL6 in the brain) | 10.1038/s41562-023-01785-5 | 2024 | Shanghai | |||||||||||||||||||||
80 | The UCMD-Causing COL6A1 (c.930 + 189C > T) Intron Mutation Leads to the Secretion and Aggregation of Single Mutated Collagen VI α1 Chains | 10.1155/2023/6892763 | basic | 2023 | Bethesda | 38.9 | -77 | USA | |||||||||||||||||
81 | Pregnancy in a woman with extreme short stature and low body weight secondary to a collagen VI-related muscular dystrophy | 10.1177/1753495X231219298 | clinical | 2023 | |||||||||||||||||||||
82 | Integration of transcriptomes of senescent cell models with multi-tissue patient samples reveals reduced COL6A3 as an inducer of senescence | 10.1016/j.celrep.2023.113371 | basic | 2023 | |||||||||||||||||||||
83 | Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells | 10.1002/path.6092 | basic | 2023 | |||||||||||||||||||||
84 | Unexpected partial RNA deletion by two different novel COL6A2 mutations leads to Ullrich congenital muscular dystrophy. | 10.1093/qjmed/hcad209 | basic | 2023 | |||||||||||||||||||||
85 | Proteomic and functional characterisation of extracellular vesicles from collagen VI deficient human fibroblasts reveals a role in cell motility | 10.1038/s41598-023-41632-1 | basic | 2023 | |||||||||||||||||||||
86 | Transcriptome profiling of skeletal muscles from Korean patients with Bethlem myopathy. | 10.1097/MD.0000000000033122 | basic | 2023 | |||||||||||||||||||||
87 | Collagen XII mediated cellular and extracellular mechanisms in development, regeneration, and disease. | 10.3389/fcell.2023.1129000 | basic | 2023 | |||||||||||||||||||||
88 | Collagen XII-Related Myopathy: An Emerging Spectrum of Extracellular Matrix-Related Myopathy | 10.4103/0028-3886.391402 | clinical | 2023 | about COL12 | ||||||||||||||||||||
89 | Collagen VI-related myopathies: clinical variability, phenotype-genotype correlation and exploratory transcriptome study | 10.1016/j.nmd.2023.03.003 | clinical | 2023 | |||||||||||||||||||||
90 | Retrospective clinical and genetic analysis of COL6-RD patients with a long-term follow-up at a single French center | 10.3389/fgene.2023.1242277 | clinical | 2023 | |||||||||||||||||||||
91 | New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients | 10.3390/ijms241512474 | clinical | 2023 | |||||||||||||||||||||
92 | Whole exome sequencing identifies a novel variant in the COL12A1 gene in a family with Ullrich congenital muscular dystrophy 2 | 10.1007/s11033-023-08644-6 | clinical | 2023 | |||||||||||||||||||||
93 | Homozygous splice variant (c.1741-6G>A) of the COL6A1 gene in three patients with Ullrich congenital muscular dystrophy | 10.1016/j.nmd.2023.05.007 | clinical | 2023 | |||||||||||||||||||||
94 | Alopecia in Patients with Collagen VI-Related Myopathies: A Novel/Unrecognized Scalp Phenotype | 10.3390/ijms24076678 | clinical | 2023 | |||||||||||||||||||||
95 | Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes | 10.3390/ijms24065551 | clinical | 2023 | |||||||||||||||||||||
96 | Collagen VI in the Musculoskeletal System | 10.3390/ijms24065095 | clinical | 2023 | |||||||||||||||||||||
97 | Bethlem Myopathy (Collagen VI-Related Dystrophies): A Retrospective Cohort Study on Musculoskeletal Pathologies and Clinical Course | 10.1097/BPO.0000000000002283 | clinical | 2023 | |||||||||||||||||||||
98 | A Diagnostic Challenge in an Adolescent with Collagen VI-Related Myopathy and Emotional Disorder—Case Report | 10.3390/jpm13111577 | diagnostic | 2023 | |||||||||||||||||||||
99 | Data augmentation study for rare diseases assessment with Deep Learning: Confocal Imaging analysis of Congenital Muscular Dystrophy | https://repositorio.upct.es/bitstream/handle/10317/13673/das.pdf?sequence=1&isAllowed=y | ML | 2023 | |||||||||||||||||||||
100 | Surgical Outcome on Bethlem Myopathy-A Case Report | 10.1016/j.neurom.2023.04.367 | therapy | 2023 |